124 related articles for article (PubMed ID: 11973647)
1. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level.
Claij N; Te Riele H
Oncogene; 2002 Apr; 21(18):2873-9. PubMed ID: 11973647
[TBL] [Abstract][Full Text] [Related]
2. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
[TBL] [Abstract][Full Text] [Related]
3. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
4. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
5. Mouse mismatch repair gene Msh2 is not essential for transcription-coupled repair of UV-induced cyclobutane pyrimidine dimers.
Sonneveld E; Vrieling H; Mullenders LH; van Hoffen A
Oncogene; 2001 Jan; 20(4):538-41. PubMed ID: 11313985
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
[TBL] [Abstract][Full Text] [Related]
7. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
Shahrzad S; Quayle L; Stone C; Plumb C; Shirasawa S; Rak JW; Coomber BL
Cancer Res; 2005 Sep; 65(18):8134-41. PubMed ID: 16166287
[TBL] [Abstract][Full Text] [Related]
8. Msh2 DNA mismatch repair gene deficiency and the food-borne mutagen 2-amino-1-methy1-6-phenolimidazo [4,5-b] pyridine (PhIP) synergistically affect mutagenesis in mouse colon.
Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
Oncogene; 2001 Sep; 20(42):6066-72. PubMed ID: 11593414
[TBL] [Abstract][Full Text] [Related]
9. Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background.
Toft NJ; Curtis LJ; Sansom OJ; Leitch AL; Wyllie AH; te Riele H; Arends MJ; Clarke AR
Oncogene; 2002 Sep; 21(41):6299-306. PubMed ID: 12214270
[TBL] [Abstract][Full Text] [Related]
10. Cell lineage-specific effects associated with multiple deficiencies of tumor susceptibility genes in Msh2(-/-)Rb(+/-) mice.
Nikitin AY; Liu CY; Flesken-Nikitin A; Chen CF; Chen PL; Lee WH
Cancer Res; 2002 Sep; 62(18):5134-8. PubMed ID: 12234974
[TBL] [Abstract][Full Text] [Related]
11. Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner.
Sansom OJ; Toft NJ; Winton DJ; Clarke AR
Oncogene; 2001 Jun; 20(27):3580-4. PubMed ID: 11429706
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.
Kohonen-Corish MR; Daniel JJ; te Riele H; Buffinton GD; Dahlstrom JE
Cancer Res; 2002 Apr; 62(7):2092-7. PubMed ID: 11929830
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
14. Evidence for Msh2 haploinsufficiency in mice revealed by MNU-induced sister-chromatid exchange analysis.
Bouffler SD; Hofland N; Cox R; Fodde R
Br J Cancer; 2000 Nov; 83(10):1291-4. PubMed ID: 11044352
[TBL] [Abstract][Full Text] [Related]
15. The mammalian mismatch repair protein MSH2 is required for correct MRE11 and RAD51 relocalization and for efficient cell cycle arrest induced by ionizing radiation in G2 phase.
Franchitto A; Pichierri P; Piergentili R; Crescenzi M; Bignami M; Palitti F
Oncogene; 2003 Apr; 22(14):2110-20. PubMed ID: 12687013
[TBL] [Abstract][Full Text] [Related]
16. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation.
Ehrenstein MR; Neuberger MS
EMBO J; 1999 Jun; 18(12):3484-90. PubMed ID: 10369687
[TBL] [Abstract][Full Text] [Related]
17. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
[TBL] [Abstract][Full Text] [Related]
18. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia.
Worrillow LJ; Allan JM
Oncogene; 2006 Mar; 25(12):1709-20. PubMed ID: 16278672
[TBL] [Abstract][Full Text] [Related]
20. DNA mismatch repair proteins promote apoptosis and suppress tumorigenesis in response to UVB irradiation: an in vivo study.
Young LC; Thulien KJ; Campbell MR; Tron VA; Andrew SE
Carcinogenesis; 2004 Oct; 25(10):1821-7. PubMed ID: 15166087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]